Swiss guidance document on the conduct of clinical trials and research projects during the COVID-19 pandemic

DUE TO THE END OF THE COVID-19 PANDEMIC, THE Swiss GUIDANCE DOCUMENT AND THE ADDENDUM TO THE PATIENT INFORMATION AND CONSENT FORM ARE NO LONGER IN FORCE. The documents are retained here for informational purposes only.

Joint guidance of swissethics - Swissmedic on the conduct of clinical trials during COVID-19 pandemic

A causa della pandemia in corso, il capitolo "Monitoraggio" è stato rivisto. La "verifica a distanza dei dati di origine remota" degli aspetti critici per la sicurezza del paziente e l'integrità dei dati è consentita in determinate condizioni nel contesto di sperimentazioni cliniche con medicamenti in tempi di pandemia.

English

2.4

updated: 18.12.2020

Addendum to the patient information / consent form of clinical trials during the COVID 19 pandemic: telephone visits and home delivery of the investigational study drug

Addendum to the patients information and consent form of clinical trials during the COVID 19 pandemic: telephone visits and home delivery of the investigational study drug

Deutsch

1.0

updated: 26.03.2020

Français

1.0

updated: 26.03.2020

Italiano

1.0

updated: 26.03.2020